Selective apoptosis of lung cancer cells with talc

European Respiratory Journal

Volumn 35, Issue 2, 2010, Pages 450-452

  Lee, P ^a   Sun, L ^a   Lim, C K ^a   Aw, S E ^a   Colt, H G ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYTOKERATIN; DOXYCYCLINE; PROPIDIUM IODIDE; SCLEROSING AGENT; SILICONE; TALC; TETRACYCLINE DERIVATIVE; TRYPSIN;

APOPTOSIS; CANCER CELL; CANCER CELL CULTURE; CANCER PALLIATIVE THERAPY; CELL POPULATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DNA CONTENT; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LETTER; LUNG ADENOCARCINOMA; LUNG CANCER; MESOTHELIUM CELL; PLEURA; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; PLEURA METASTASIS; PLEURODESIS; PRIORITY JOURNAL; TARGET CELL; THORACOCENTESIS;

ADENOCARCINOMA; APOPTOSIS; CELL LINE, TUMOR; FIBROSIS; HUMANS; INFLAMMATION; LUNG; LUNG NEOPLASMS; NEOPLASM METASTASIS; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; TALC;

EID: 76149084842     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00113109     Document Type: Letter

References (10)

1. Antunes G, Neville E, Duffy J, et al. BTS guidelines for the management of malignant pleural effusions. Thorax 2003; 58: Suppl. 2, ii29-ii38.
2. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004; 1: CD002916.
3. Lee YC, Baumann MH, Maskell NA, et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 2003; 124: 2229-2238.
4. Toh HC, Sun L, Koh CH, et al. Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine. Leuk Lymphoma 1998; 31: 195-208.
5. Tan DT, Liu YP, Sun L. Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest Ophthalmol Vis Sci 2000; 41: 1684-1686.
6. Hartman DL, Gaither JM, Kesler KA, et al. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 1993; 105: 743-747.
7. Viallat JR, Rey F, Astoul P, et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 1996; 110: 1387-1393.
8. Marchi E, Vargas FS, Acencio MM, et al. Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis. Eur Respir J 2006; 28: 929-932.
9. Antony VB, Nasreen N, Mohammed KA, et al. Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis. Chest 2004; 126: 1522-1528.
10. Nasreen N, Mohammed KA, Brown S, et al. Talc mediates angiostasis in malignant pleural effusions via endostatin induction. Eur Respir J 2007; 29: 761-769.